A new AI framework targets one of the main failure modes in medical machine learning: uncertainty quantification in cancer subtyping. The work, framed around recognizing when a model encounters inputs outside its training distribution, aims to improve clinical reliability for deep learning diagnostics. The approach focuses on quantifying uncertainty so clinicians can interpret outputs with clearer confidence bounds—important for medical AI systems deployed in heterogeneous patient settings. Unfamiliar input handling is a core barrier to scaling AI tools beyond controlled datasets. For oncology teams, the development matters because subtyping drives treatment selection and trial stratification, and unreliable models can lead to misclassification risk when tumor biology or imaging patterns differ from training examples. The near-term impact will depend on whether the framework improves performance in real-world datasets and whether it can be integrated into existing cancer diagnostic pipelines without adding prohibitive computational or regulatory burden.